证券代码：688102 证券简称：斯瑞新材 公告编号：2024-024 陕西斯瑞新材料股份有限公司 2023 年度募集资金存放与实际使用情况的专项报告 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意陕西斯瑞新材料股份有限公司首次 公开发行股票注册的批复》（证监许可〔2022〕【162】号）同意，公司首次公 开发行股票的注册申请。并经上海证券交易所同意，公司首次向社会公开发行人 民币普通股（A 股）股票 40,010,000 股，本次发行价格为每股人民币 10.48 元， 募集资金总额为人民币 41,930.48 万元，扣除发行费用人民币（不含增值税） 6,239.40 万元后，实际募集资金净额为人民币 35,691.08 万元。本次发行募集 资金已于 2022 年 3 月 11 日全部到位，并经致同会计师事务所（特殊普通合伙） 审验，于 2022 年 3 月 11 日出具了《验资报告》（致同验字（2022）第 332C000120 号）。 （二）募集资金使用和结余情况 截止 2023 年 12 月 31 日，公司已累计使用募集资金 35,774.42 万元，2 ...

陕西斯瑞新材料股份有限公司 2023 年度独立董事述职报告（李静） 作为陕西斯瑞新材料股份有限公司（以下简称"公司"或"斯瑞新材"）的 独立董事，报告期内，我严格按照《中华人民共和国公司法》（以下简称"《公 司法》"）《中华人民共和国证券法》（以下简称"《证券法》"）等法律法规以 及《陕西斯瑞新材料股份有限公司章程》《陕西斯瑞新材料股份有限公司独立董 事工作制度》的要求，本着客观、公正、独立的原则，勤勉尽责、独立履职，及 时了解公司的生产经营及发展情况，准时出席相关会议，积极发挥独立董事作用， 有效维护了公司整体利益和全体股东的合法权益。现将 2023 年度履行独立董事 职责情况汇报如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 李静女士，1978 年生，中国国籍，无境外永久居留权。西安交通大学硕士研 究生，希格玛会计师事务所（特殊普通合伙）合伙人。中国注册会计师、中国注 册税务师、澳洲注册会计师、财政部全国会计领军人才（金融审计）。多年从事 审计咨询工作，主要负责上市公司审计咨询、金融机构审计咨询、公司债企业债 发债审计、境内境外企业审计咨询、企业行政事业单位内部控制咨询业务。曾受 ...

经深入核查独立董事袁养德先生、耿英三先生、李静女士个人签署的相关 自查文件,董事会确认各位独立董事在报告期内未在公司担任除独立董事以外 的任何职务,亦未在公司的主要股东单位中担任任何职务。独立董事与公司及 其主要股东之间不存在任何形式的利益冲突、关联关系或其他可能对其独立客 观判断产生影响的情况。公司独立董事在 2023年度始终保持高度的独立性,其 履职行为符合《上市公司独立董事管理办法》《上市公司治理准则》以及《公司 章程》中关于独立董事独立性的严格规定和要求，有效地履行了独立董事的职 责, 为公司决策提供了公正、独立的专业意见。 陕西斯瑞新材料服 一、独立董事独立性自查情况 陕西斯瑞新材料股份有限公司(以下简称"公司")现有独立董事 3人,分 别为袁养德先生、耿英三先生、李静女士。根据《上市公司独立董事管理办 法》第六条的规定,公司独立董事对自身的独立性情况进行了自查,并将自查 情况提交了董事会。自查结果显示，公司独立董事均符合《上市公司独立董事 管理办法》第六条的独立性要求，不存在直接或者间接利害关系,或者其他可 能影响其进行独立客观判断关系的情形,能够独立履行职责,不受公司及其主 要股东、实际控制人等 ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥287,217,967.31, representing a year-on-year increase of 14.26%[5] - The net profit attributable to shareholders for the same period was ¥24,562,633.21, reflecting a growth of 13.49% compared to the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥21,269,652.17, which is an increase of 13.73% year-on-year[5] - The basic earnings per share (EPS) for Q1 2024 was ¥0.0453, up by 17.36% from the same period last year[5] - Total operating revenue for Q1 2024 reached ¥287,217,967.31, an increase of 14.26% compared to ¥251,372,240.85 in Q1 2023[17] - Net profit for Q1 2024 was ¥24,736,345.59, representing a 16.52% increase from ¥21,124,595.85 in Q1 2023[18] - Earnings per share for Q1 2024 were ¥0.0453, compared to ¥0.0386 in Q1 2023, reflecting a growth of 17.29%[19] Assets and Liabilities - The total assets at the end of the reporting period reached ¥1,875,048,091.28, marking a 9.31% increase from the end of the previous year[6] - The company's total liabilities increased to CNY 817,818,142.31, compared to CNY 716,431,308.45, indicating a growth of about 14.1%[13] - The total liabilities increased to ¥781,151,499.35 in Q1 2024, compared to ¥624,727,842.68 in Q1 2023, marking a rise of 25.05%[15] - Non-current liabilities rose to ¥287,045,665.03 in Q1 2024, up from ¥200,394,971.97 in Q1 2023, an increase of 43.24%[15] Cash Flow - The net cash flow from operating activities was negative at -¥32,824,301.06, primarily due to increased raw material purchases[8] - Cash inflow from operating activities in Q1 2024 was ¥254,880,484.09, slightly up from ¥253,533,651.85 in Q1 2023[19] - The net cash flow from operating activities was -$32,824,301.06, a significant decline compared to -$3,914,208.31 in the previous year, indicating a worsening operational cash flow situation[21] - The cash flow from operating activities showed a cash outflow of $287,704,785.15, compared to $257,447,860.16, highlighting increased operational costs[21] Investments and Financing - The company reported an investment income of ¥116,838.91 in Q1 2024, a significant recovery from a loss of ¥404,993.50 in Q1 2023[18] - The net cash flow from financing activities increased to $129,254,049.91, compared to $15,296,110.83 in the same quarter last year, showing strong financing support[21] - The company received $137,280,000.00 in borrowings, significantly higher than $50,000,000.00 in the previous year, indicating increased leverage[21] - The cash inflow from financing activities of $227,842,600.00, a substantial increase from $53,000,000.00, reflecting strong investor confidence[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,541[10] - The company has not reported any significant changes in its shareholder structure or any new strategies during the reporting period[12] Research and Development - Research and development (R&D) expenses totaled ¥14,525,220.21, which is 5.06% of operating revenue, an increase of 0.24 percentage points year-on-year[6] - Research and development expenses for Q1 2024 were ¥14,525,220.21, up from ¥12,108,028.44 in Q1 2023, indicating a growth of 20.00%[17] Other Information - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[12] - The company reported non-recurring gains of ¥3,292,981.04 for the period, which included government subsidies and asset disposal gains[8]

证券代码：688102 证券简称：斯瑞新材 公告编号：2024-026 陕西斯瑞新材料股份有限公司 关于开展外汇套期保值业务的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 为有效规避和防范汇率波动风险，提高外汇资金使用效率，合理降低财务费用， 陕西斯瑞新材料股份有限公司（以下简称"公司"）（含控股子公司）拟以自有资金 开展外汇套期保值业务，公司进行的外汇套期保值业务规模总额不超过 6,000 万美元 或其他等值货币，预计动用的交易保证金和权利金上限（包括为交易而提供的担保物 价值、预计占用的金融机构授信额度、为应急措施所预留的保证金等）则不超过 100 万美元或其他等值货币。额度有效期为自公司董事会审议通过之日起 12 个月，在上述 期限和额度范围内，可循环滚动使用。 本事项已经公司第三届董事会第十二次会议、第三届监事会第十次会议审议通 过，保荐机构发表了无异议的核查意见，本事项无需提交股东大会审议。 特别风险提示：公司进行外汇套期保值业务遵循稳健原则，不进行以投机为目 的的外汇交易，所有外汇套期保值业 ...

根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，我们对公司2023年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 陕西斯瑞新材料股份有限公司 2023 年度内部控制评价报告 陕西斯瑞新材料股份有限公司全体股东： 公司代码：688102 公司简称：斯瑞新材 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供 合理保证。此外，由于情况的变化 ...

2023 年度独立董事述职报告（耿英三） 作为陕西斯瑞新材料股份有限公司（以下简称"公司"或"斯瑞新材"）的 独立董事，报告期内，我严格按照《中华人民共和国公司法》（以下简称"《公 司法》"）《中华人民共和国证券法》（以下简称"《证券法》"）等法律法规以 及《陕西斯瑞新材料股份有限公司章程》《陕西斯瑞新材料股份有限公司独立董 事工作制度》的要求，本着客观、公正、独立的原则，勤勉尽责、独立履职，及 时了解公司的生产经营及发展情况，准时出席相关会议，积极发挥独立董事作用， 有效维护了公司整体利益和全体股东的合法权益。现将 2023 年度履行独立董事 职责情况汇报如下： 耿英三先生，西安交通大学教授（二级），博士研究生导师。分别于 1984 年、 1987 年、1997 年于西安交通大学获得学士、硕士、博士学位。1987 年 6 月留校 任教至今。现任西安交通大学电工材料电气绝缘全国重点实验室副主任，西安交 通大学电气学院电器装备及智能化系统研究所所长。2000 年入选教育部高等学 校骨干教师，2004 年入选教育部"新世纪优秀人才支持计划"。 一、独立董事的基本情况 陕西斯瑞新材料股份有限公司 （一）个人工作履历 ...

证券代码：688102 证券简称：斯瑞新材 公告编号：2024-030 重要内容提示： 陕西斯瑞新材料股份有限公司 关于召开 2023 年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 股东大会召开日期：2024年5月17日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 （一） 股东大会类型和届次 2023 年年度股东大会 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2024 年 5 月 17 日 14 点 00 分 召开地点：陕西斯瑞新材料股份有限公司 4 楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2024 年 5 月 17 日至 2024 年 5 月 17 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交 ...

Financial Performance - The company reported a revenue of RMB 1.2 billion for the fiscal year 2023, representing a year-over-year growth of 15%[21]. - The company's operating revenue for 2023 reached approximately ¥1.18 billion, representing an 18.71% increase compared to 2022[25]. - Net profit attributable to shareholders for 2023 was approximately ¥98.34 million, a 26.04% increase from the previous year[25]. - The basic earnings per share for 2023 was ¥0.1756, reflecting a 22.88% growth year-over-year[25]. - The net cash flow from operating activities surged by 227.56% to approximately ¥168.57 million in 2023[25]. - The company's total assets increased by 14.57% to approximately ¥1.72 billion by the end of 2023[25]. - The weighted average return on equity rose to 9.58%, an increase of 0.66 percentage points compared to 2022[25]. - The company reported a 54.21% increase in net profit after deducting non-recurring gains and losses, reaching approximately ¥81.19 million[25]. - The company achieved a total revenue of CNY 1,179,512,989.96 in 2023, representing an 18.71% increase compared to the previous year[119]. - The net profit attributable to shareholders was CNY 98,341,100, reflecting a growth of 26.04% year-over-year[119]. - The net profit after deducting non-recurring gains and losses increased by 54.21%, amounting to CNY 81,193,000[119]. Dividend and Share Capital - The company plans to distribute a cash dividend of 0.80 CNY per 10 shares, totaling approximately 47.51 million CNY, which represents 48.31% of the net profit attributable to shareholders for 2023[5]. - The company intends to increase its share capital by 3 shares for every 10 shares held, resulting in an increase of approximately 167.32 million shares, raising the total share capital to approximately 727.34 million shares[6]. - The total cash dividend amount for 2023 is projected to be 47,507,356.86 CNY (including tax), which represents 48.31% of the net profit attributable to shareholders for the year[200]. - The company’s profit distribution policy prioritizes cash dividends when conditions are met, with a minimum of 30% of the average distributable profit over the last three years to be distributed in cash[199]. - The company has a total share capital of 560,014,000 shares as of the latest report, after the previous year's capital increase[200]. - The company repurchased shares worth 2,887,652.78 CNY in 2023, which is considered as part of the cash dividend distribution[200]. Research and Development - The company is investing RMB 100 million in R&D for advanced imaging technologies over the next two years[21]. - The company invested CNY 59.453 million in R&D during the reporting period, representing a year-on-year increase of 15.19%[43]. - The total R&D investment for the year was approximately ¥59.45 million, representing a 15.19% increase from the previous year[92]. - The company has obtained 45 new independent intellectual property authorizations, bringing the total to 257 authorized invention patents by the end of the reporting period[43]. - The company has a research team of 98 members, accounting for 8.15% of total employees, emphasizing its commitment to R&D[109]. - The company is actively pursuing partnerships with research institutions to drive innovation and address industry challenges[107]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 10% increase in market penetration by the end of 2024[21]. - The company is focusing on digital transformation to enhance operational efficiency and optimize sales structure[28]. - The company aims to achieve a market share of over 50% globally in its niche materials sectors through innovation and capacity expansion[155]. - The company plans to double its international market business over the next three years, building on an export business of approximately RMB 285 million in 2023[156]. - The company is exploring potential acquisitions to enhance its product portfolio, with a budget of 500 million RMB allocated for this purpose[176]. Corporate Governance - The company has established a clear governance structure with various committees to ensure effective management and decision-making[159]. - The independent directors' performance report for the year was approved, ensuring governance standards are maintained[161]. - The company has appointed new independent directors to enhance governance and oversight, ensuring compliance with regulatory standards[169]. - The company has not faced any significant adverse impacts from competition with its controlling shareholder[164]. Risks and Challenges - The company has identified potential risks in its business development, which are detailed in the management discussion and analysis section[4]. - The company is exposed to risks from raw material price fluctuations, particularly copper, which could impact operational performance[112]. - The company faces risks related to technology upgrades, as competition from developed countries poses a threat to its market position[109]. Sustainability Initiatives - The company has set a target to achieve carbon neutrality by 2030, aligning with the dual carbon goals[21]. - The company aims to reduce carbon emissions by 20% over the next three years as part of its sustainability initiatives[173]. - The management team emphasized a commitment to sustainability, with initiatives aimed at reducing carbon emissions by 30% by 2025[176]. Employee and Management Changes - The company has appointed a new general manager, Zhang Hang, and a new deputy general manager, Miao Weiguo, due to the need for development layout[181]. - Independent director Zhang Weiqi resigned for personal reasons, while independent director Geng Yingsan was elected to fill a vacancy[181]. - The total compensation for directors, supervisors, and senior management at the end of the reporting period amounted to 650.55 million[180]. - The total compensation for core technical personnel at the end of the reporting period was 177.24 million[180].

证券代码：688102 证券简称：斯瑞新材 公告编号：2024-023 陕西斯瑞新材料股份有限公司（以下简称"公司"）本项日常关联交易 均是公司及子公司正常生产经营所必需，定价公允、结算时间与方式合理，不损 害公司及中小股东的利益。公司选择的合作关联方均具备良好商业信誉和财务状 况，可降低公司的经营风险，有利于公司正常业务的持续开展，在同类交易中占 比较小，公司主要业务不会因此形成对关联方的依赖，不影响公司的独立性。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 2024 年 4 月 24 日，公司第三届董事会独立董事专门会议第三次会议审议通 过了《关于预计公司 2024 年度日常关联交易的议案》，表决结果：3 票同意，0 票反对，0 弃权。独立董事对该议案进行审议并发表意见如下：公司及子公司与 关联方的日常关联交易为公司正常经营业务，有利于公司业务稳定持续发展；关 联交易价格公允，交易方式符合市场规则，不会对公司独立性产生影响。上述议 案审议和表决程序符合《公司章程》和上海证券交易所的有关规定；不存在损害 公司全体股东权益，特别是中小股东权益的情形。并同意将该关联交易事项提交 公司董事会进行审 ...